Warner Chilcott confirms higher approach

The battle for Warner Chilcott moved to the next round today when the drugs group confirmed an approach that could value it at more than £1.5bn (€2.15bn).

The Northern Ireland-based company, which changed its name from Galen in May, said the move could lead to an offer valuing its shares at 837p each – higher than the 800p previously indicated.